ELIZABETH DEDDO: Open Payments
NPI 1215458187 · URBANA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 24 payments from 10 companies in 2025. Trend: 2023 $374 · 2024 $376 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $121 |
| Madrigal Pharmaceuticals | 3 | $92 |
| Ipsen Biopharmaceuticals, Inc | 4 | $75 |
| Aimmune Therapeutics, Inc. | 3 | $70 |
| QOL Medical, LLC | 2 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Mallinckrodt Hospital Products Inc. | 1 | $35 |
| Organon LLC | 1 | $23 |
| ORPHALAN INC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: REZDIFFRA, IQIRVO, SKYRIZI, Sucraid, ZENPEP, XIFAXAN, RINVOQ, TERLIVAZ.
Industry payments across IL — which companies pay providers there.
